Oncopeptides AB, ONCO: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events, Short

Welcome to Oncopeptides AB’s (publ) website. In order to optimize your use of our website we use cookies. A cookie is a text file stored on your computer. If you want more information about what a cookie is, what the purpose of the cookie is and how you can block or delete cookies, please read the our cookie guidelines “About cookies”.

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. On Wednesday, Oncopeptides AB (ONCO:STO) closed at 152.20, -29.21% below its 52-week high of 215.00, set on Mar 01, 2021. Shares in Oncopeptides AB are currently priced at SEK160. At that level they are trading at 48.19% discount to the analyst consensus target price of 0.00. Analysts covering Oncopeptides AB currently have a consensus Earnings Per Share (EPS) forecast of -19.54 for the next financial year. US stock market today: stock quotes, stock screener, stock charts, insiders trading, market news, portfolio tracking, and cryptocurrencies. Oncopeptides AB (publ) (ONPPF) Stock Price History | wallmine Compiled here, all relevant comments and discussions regarding the ONCO Stock.

Start a 14-day free trial to Morningstar Premium to unlock our take on ONPPF. 2021-04-16 So we'll take a look at whether insiders have been buying or selling shares in Oncopeptides AB (publ) . What Is Insider Buying? It's quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, rules govern … A high-level overview of ONCOPEPTIDES AB AK (ONPPF) stock.

ONCOPEPTIDES AB 0RN4 Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals ONCOPEPTIDES AB (PUBL): Veröffentlichung des Quartalsergebnisses: 2020: ONCOPEPTIDES AB (PUBL): publication des résultats trimestriels: 2020: AVIS D'ANALYSTES DU JOUR: Airbus, LVMH, Ubisoft, bioMérieux, ArgenX, Moncler, S.. 2020: STOCK MARKET PARIS: Les marchés replongent dans les résultats d'entreprises Oncopeptides AB, ONCO: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events, Short Oncopeptides AB (publ) Stock Signals OMX:ONCO Latest Data & Signals Issued.

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that the Company has

This information is information that Oncopeptides is obliged to make public pursuant to the EU Market Abuse Regulation. Oncopeptides lämnar in ansökan om villkorat marknadsgodkännande för melflufen i EU fre, apr 16, 2021 08:00 CET. STOCKHOLM — 16 april 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), ett globalt biotechbolag som utvecklar riktade behandlingar för svårbehandlade hematologiska sjukdomar, tillkännager idag att bolaget lämnat in en ansökan till den europeiska We are now looking for yet another Clinical Study Physician for Oncopeptides. The company, which is listed on the Stockholm Stock Exchange, was founded in Sweden year 2000 and operates globally.

Få omedelbar tillgång till ett gratis live streamade diagram för Oncopeptides AB aktien. Detta unika "område" i diagrammet gör det möjligt att tydligt upptäcka beteendet Oncopeptides hos aktien inom de senaste 3 timmars handel, samt förse dig med viktiga data såsom daglig förändring, höga och låga kurser.

Other OTC - Other OTC Delayed price.

BioInvent International AB. kr 46.50-1.27%. Cantargia AB. kr 28.85-1.87%. Stora Enso Ord Shs Class R. Oncopeptides AB (ONCO.ST) Stock Price, News, Quote — Oncopeptides är en aktie för Oncopeptides AB med ISIN-beteckning SE. Oncopeptides AB is a clinical development stage pharmaceutical company The 5% share represents a market value of SEK 26.7 milli. >@Giovanni Cancemi/Shutterstock Oncopeptides AB är ett börsnoterat läkemedelsföretag fokuserat på utvecklingen av riktade terapier för Created with Highstock Onco.
Utdelning nordea aktie 2021

However, rules govern insider transactions, and certain disclosures are required. Pay attention to that the links below are to external websites. They are beyond the control of Oncopeptides AB (publ) and are not covered by our privacy policy.

Company profile page for Oncopeptides AB including stock price, company news, press releases, executives, board members, and contact information View the latest Oncopeptides AB (ONCO) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get Oncopeptides AB (OND-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC.
Elos medtech årsredovisning 2021

Få detaljerad information om Oncopeptides AB (ONCO) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Oncopeptides rapporter

The Company’s lead product candidate PEPAXTO (melphalan flufenamide, also known as melflufen) has been approved in relapsed or refractory multiple myeloma by The U.S. Food and Drug Administration. Oncopeptides AB (publ) Stock Forecast, OND stock price prediction.

Enkla cv mallar

Oncopeptides AB. kr 156.60-2.97%. BioInvent International AB. kr 46.50-1.27%. Cantargia AB. kr 28.85-1.87%. Stora Enso Ord Shs Class R.

The public information regarding Oncopeptides AB's current market price is not available at this time. ONCOPEPTIDES AB 0RN4 Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals Get Oncopeptides AB (OND-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. ONCOPEPTIDES AB (PUBL) (STO:ONCO) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share ONCOPEPTIDES AB (PUBL) | NASDAQ STOCKHOLM AB: ONCO | NASDAQ STOCKHOLM AB Oncopeptides AB (publ), a pharmaceutical company, develops pharmaceuticals drugs for the treatment of cancer. More Details.

Get the most recent insider transactions for Oncopeptides AB (ONCO). Check whether executives and directors are buying or selling the stock.

This information is information that Oncopeptides is obliged to make public Find the latest ONCOPEPTIDES AB O.N. (OND.F) stock quote, history, news and other vital information to help you with your stock trading and investing. for-phone-only for-tablet-portrait-up for-tablet-landscape-up for-desktop-up for-wide-desktop-up IPO.se • 16 Aug 2019 19:00 Oncopeptides meddelar att data accepterats för presentation vid International Myeloma Workshop, mellan den 12-15 september. Stockholm - 16 augusti 2019 - Oncopeptides AB (Nasdaq Stockholm: ONCO) meddelade idag att en oral ”late breaking” presentation med uppdaterade melflufen data från den pivotala fas 2-studien OP-106 HORIZON likväl som två postrar kommer Get Oncopeptides AB (ONCO:Stockholmsborsen) real-time stock quotes, news, price and financial information from CNBC. Oncopeptides AB (publ) Västra Trädgårdsgatan 15, SE-111 53 Stockholm, Sweden 200 Fifth Avenue, Suite #1030 Waltham, MA 02451 So we'll take a look at whether insiders have been buying or selling shares in Oncopeptides AB (publ) . What Is Insider Buying?

The company, which is listed on the Stockholm Stock Exchange, was founded in Sweden year 2000 and operates globally. Oncopeptides develops drugs for the treatment of cancer/hematology and is in a very exciting phase of development. We are searching a Health Economics and Outcomes Research Manager for Oncopeptides. The company, which is listed on the Stockholm Stock Exchange, was founded in Sweden year 2000 and operates globally.